Global Organ Transplant Immunosuppressant Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, and Other Drug Classes), By Transplant Type (Kidney, Liver, Heart, Lung, Pancreas, and Other Transplant Types), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Jun 2025
REPORT ID SI11510
PAGES 230
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Transplant Type
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing number of organ transplants
      2. Prevalence of chronic diseases such as kidney failure, cirrhosis, heart failure, and lung diseases
    3. Restraints
      1.  Increased cost and side effects associated with the drug administration
    4. Opportunities
      1. Development of personalized therapy for managing the immune response as per the individual patient characteristics
    5. Challenges
      1. Donor organ shortage and challenges with patient compliance
  6. Global Organ Transplant Immunosuppressant Drugs Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Calcineurin Inhibitors
    3. Antiproliferative Agents
    4. mTOR Inhibitor
    5. Steroids
    6. Other Drug Classes
  7. Global Organ Transplant Immunosuppressant Drugs Market Analysis and Projection, By Transplant Type
    1. Segment Overview
    2. Kidney
    3. Liver
    4. Heart
    5. Lung
    6. Pancreas
    7. Other Transplant Types
  8. Global Organ Transplant Immunosuppressant Drugs Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Organ Transplant Immunosuppressant Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Organ Transplant Immunosuppressant Drugs Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Astellas Pharma d.o.o.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Accord Healthcare 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Novartis AG 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Viatris Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  F. Hoffmann-La Roche Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   GlaxoSmithKline plc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Veloxis Pharmaceuticals, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Bristol-Myers Squibb Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  2. Global Calcineurin Inhibitors, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  3. Global Antiproliferative Agents, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  4. Global mTOR Inhibitor, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  5. Global Steroids, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  6. Global Other Drug Classes, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  7. Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  8. Global Kidney, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  9. Global Liver, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  10. Global Heart, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  11. Global Lung, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  12. Global Pancreas, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  13. Global Other Transplant Types, Organ Transplant Immunosuppressant Drugs Market, By Region, 2024-2035(USD Billion)
  14. North America Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  15. North America Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  16. U.S.  Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  17. U.S.  Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  18. Canada Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  19. Canada Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  20. Mexico Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  21. Mexico Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  22. Europe Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  23. Europe Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  24. Germany Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  25. Germany Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  26. France Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  27. France Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  28. U.K.  Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  29. U.K.  Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  30. Italy Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  31. Italy Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  32. Spain Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  33. Spain Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  34. Asia Pacific Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  35. Asia Pacific Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  36. Japan Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  37. Japan Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  38. China Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  39. China Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  40. India Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  41. India Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  42. South America Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  43. South America Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  44. Brazil Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  45. Brazil Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  46. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD   Billion)
  47. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD   Billion)
  48. UAE Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  49. UAE Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)
  50. South Africa Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2024-2035(USD Billion)
  51. South Africa Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2024-2035(USD Billion)

List of Figures 

  1. Global Organ Transplant Immunosuppressant Drugs Market Segmentation
  2. Organ Transplant Immunosuppressant Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Organ Transplant Immunosuppressant Drugs Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Organ Transplant Immunosuppressant Drugs Market
  20. Organ Transplant Immunosuppressant Drugs Market Segmentation, By Drug Class
  21. Organ Transplant Immunosuppressant Drugs Market For Calcineurin Inhibitors, By Region, 2024-2035 ($ Billion)
  22.  Organ Transplant Immunosuppressant Drugs Market For Antiproliferative Agents, By Region, 2024-2035 ($ Billion)
  23. Organ Transplant Immunosuppressant Drugs Market For mTOR Inhibitor, By Region, 2024-2035 ($ Billion)
  24. Organ Transplant Immunosuppressant Drugs Market For Steroids, By Region, 2024-2035 ($ Billion)
  25. Organ Transplant Immunosuppressant Drugs Market For Other Drug Classes, By Region, 2024-2035 ($ Billion)
  26.  Organ Transplant Immunosuppressant Drugs Market Segmentation, By Transplant Type
  27.  Organ Transplant Immunosuppressant Drugs Market For Kidney, By Region, 2024-2035 ($ Billion)
  28.  Organ Transplant Immunosuppressant Drugs Market For Liver, By Region, 2024-2035 ($ Billion)
  29. Organ Transplant Immunosuppressant Drugs Market For Heart, By Region, 2024-2035 ($ Billion)
  30. Organ Transplant Immunosuppressant Drugs Market For Lung, By Region, 2024-2035 ($ Billion)
  31. Organ Transplant Immunosuppressant Drugs Market For Pancreas, By Region, 2024-2035 ($ Billion)
  32. Organ Transplant Immunosuppressant Drugs Market For Other Transplant Types, By Region, 2024-2035 ($ Billion)
  33. Astellas Pharma d.o.o.: Net Sales, 2024-2035 ($ Billion)
  34. Astellas Pharma d.o.o.: Revenue Share, By Segment, 2024 (%)
  35. Astellas Pharma d.o.o.: Revenue Share, By Region, 2024 (%)
  36. Sanofi: Net Sales, 2024-2035 ($ Billion)
  37. Sanofi: Revenue Share, By Segment, 2024 (%)
  38. Sanofi: Revenue Share, By Region, 2024 (%)
  39. Accord Healthcare: Net Sales, 2024-2035 ($ Billion)
  40. Accord Healthcare: Revenue Share, By Segment, 2024 (%)
  41. Accord Healthcare: Revenue Share, By Region, 2024 (%)
  42. Novartis AG: Net Sales, 2024-2035 ($ Billion)
  43. Novartis AG: Revenue Share, By Segment, 2024 (%)
  44. Novartis AG: Revenue Share, By Region, 2024 (%)
  45. Viatris Inc.: Net Sales, 2024-2035 ($ Billion)
  46. Viatris Inc.: Revenue Share, By Segment, 2024 (%)
  47. Viatris Inc.: Revenue Share, By Region, 2024 (%)
  48. F. Hoffmann-La Roche Ltd: Net Sales, 2024-2035 ($ Billion)
  49. F. Hoffmann-La Roche Ltd: Revenue Share, By Segment, 2024 (%)
  50. F. Hoffmann-La Roche Ltd: Revenue Share, By Region, 2024 (%)
  51. GlaxoSmithKline plc.: Net Sales, 2024-2035 ($ Billion)
  52. GlaxoSmithKline plc.: Revenue Share, By Segment, 2024 (%)
  53. GlaxoSmithKline plc.: Revenue Share, By Region, 2024 (%)
  54. Veloxis Pharmaceuticals, Inc.: Net Sales, 2024-2035 ($ Billion)
  55. Veloxis Pharmaceuticals, Inc.: Revenue Share, By Segment, 2024 (%)
  56. Veloxis Pharmaceuticals, Inc.: Revenue Share, By Region, 2024 (%)
  57. Bristol-Myers Squibb Company.: Net Sales, 2024-2035 ($ Billion)
  58. Bristol-Myers Squibb Company.: Revenue Share, By Segment, 2024 (%)
  59. Bristol-Myers Squibb Company.: Revenue Share, By Region, 2024 (%)
  60. Others: Net Sales, 2024-2035 ($ Billion)
  61. Others: Revenue Share, By Segment, 2024 (%)
  62. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:130
Pages:230
Countries covered:17
Companies covered::20
Forecast CAGR:4.53%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies